About Evolus, Inc.
https://www.evolus.comEvolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.

CEO
David Moatazedi
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 72
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership

NANTAHALA CAPITAL MANAGEMENT, LLC
Shares:5.73M
Value:$28.75M

TANG CAPITAL MANAGEMENT LLC
Shares:5.49M
Value:$27.55M

BLACKROCK, INC.
Shares:4.48M
Value:$22.47M
Summary
Showing Top 3 of 184
About Evolus, Inc.
https://www.evolus.comEvolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $68.97M ▼ | $57.34M ▲ | $-15.74M ▲ | -22.82% ▲ | $-0.24 ▲ | $-9.52M ▼ |
| Q2-2025 | $69.39M ▲ | $55.53M ▼ | $-17.14M ▲ | -24.7% ▲ | $-0.27 ▲ | $-7.83M ▲ |
| Q1-2025 | $68.52M ▼ | $61.83M ▲ | $-18.89M ▼ | -27.57% ▼ | $-0.3 ▼ | $-12.58M ▼ |
| Q4-2024 | $78.95M ▲ | $52.66M ▼ | $-6.79M ▲ | -8.6% ▲ | $-0.11 ▲ | $625K ▲ |
| Q3-2024 | $61.09M | $58.34M | $-19.17M | -31.38% | $-0.3 | $-13M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $43.52M ▼ | $219M ▼ | $247.76M ▲ | $-28.76M ▼ |
| Q2-2025 | $61.74M ▼ | $228.8M ▲ | $247.46M ▲ | $-18.65M ▼ |
| Q1-2025 | $67.89M ▼ | $213.36M ▼ | $219.97M ▼ | $-6.6M ▼ |
| Q4-2024 | $86.95M ▲ | $232.57M ▲ | $227.05M ▲ | $5.52M ▼ |
| Q3-2024 | $85.03M | $229.61M | $223.72M | $5.89M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-15.74M ▲ | $-14.67M ▲ | $-2.16M ▲ | $-1.77M ▼ | $-18.21M ▼ | $-16.83M ▲ |
| Q2-2025 | $-17.14M ▲ | $-24.79M ▼ | $-2.27M ▼ | $20.66M ▲ | $-6.16M ▲ | $-25.48M ▼ |
| Q1-2025 | $-18.89M ▼ | $-15.63M ▼ | $-1.86M ▼ | $-1.63M ▼ | $-19.06M ▼ | $-17.49M ▼ |
| Q4-2024 | $-6.79M ▲ | $4.81M ▲ | $-1.36M ▲ | $-1.31M ▲ | $1.92M ▲ | $3.45M ▲ |
| Q3-2024 | $-19.17M | $-5.72M | $-1.41M | $-1.42M | $-8.64M | $-7.13M |
Revenue by Products
| Product | Q4-2024 | Q3-2025 | Q2-2025 | Q1-2025 |
|---|---|---|---|---|
Product | $80.00M ▲ | $70.00M ▼ | $70.00M ▲ | $70.00M ▲ |
Service | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q3-2020 | Q2-2021 | Q1-2022 |
|---|---|---|---|
CANADA | $0 ▲ | $0 ▲ | $0 ▲ |

CEO
David Moatazedi
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 72
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership

NANTAHALA CAPITAL MANAGEMENT, LLC
Shares:5.73M
Value:$28.75M

TANG CAPITAL MANAGEMENT LLC
Shares:5.49M
Value:$27.55M

BLACKROCK, INC.
Shares:4.48M
Value:$22.47M
Summary
Showing Top 3 of 184









